Volume 6, Issue 2 supplement | PharmacoEconomics

Search all PharmacoEconomics articles

Volume 6, Issue 2 supplement

December 1994

Filter by

Volume:

Sort by

Date published:

New to old Old to new

7 articles in this issue

Colony-Stimulating Factors
R. M. Fox
OriginalPaper 17 November 2012 Pages: 1 - 8
Overview of the Lenograstim Pharmacoeconomics Programme
G. Oster
J. Menzin
V. Cour-Chabernaud
OriginalPaper 17 November 2012 Pages: 9 - 17
Methodological Issues in Economic Assessments of New Therapies
M. Drummond
J. Menzin
G. Oster
OriginalPaper 17 November 2012 Pages: 18 - 26
Economic Evaluation of Lenograstim (Glycosylated rHuG-CSF) in the Treatment of Inflammatory Breast Cancer for Germany and Italy
V. Mapelli
J. -M. Graf v.d. Schulenburg
F. Rossi
OriginalPaper 17 November 2012 Pages: 27 - 35
Economic Analysis of Lenograstim in the Correction of Neutropenia Following Chemotherapy for Non-Hodgkin’s Lymphoma
Eric Souêtre
Wen Qing
OriginalPaper 17 November 2012 Pages: 36 - 43
Economic Evaluation of Lenograstim for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Small Cell Lung Cancer
Michael Drummond
Linda Davies
OriginalPaper 17 November 2012 Pages: 44 - 52
Pharmacoeconomic Evaluation of Lenograstim
Joseph Menzin
Gerry Oster
Denise Richard
OriginalPaper 17 November 2012 Pages: 53 - 60